91制片厂 researchers have discovered that bacteria can sense threats in advance through a general danger signal. Bacteria detect when nearby cells are dying and proactively form a protective biofilm. Understanding how bacteria communicate and respond to threats is crucial for combating infections.
How are refugees supported before and during their studies at the university? An interview with Anna Meier, Head of the Coordination Office for Refugees.
Whether on your bank鈥檚 website or your telephone provider鈥檚 help line, interactions between humans and chatbots have become part of our daily lives. But do we trust them? And what factors influence our trust? Researchers at the 91制片厂 recently examined these questions.
Researchers have developed a therapy to treat Stargardt disease, the most common form of inherited macular degeneration, which often leads to vision loss. Their study shows promising results using a precise technique for gene correction.
It鈥檚 once again time for one of the most famous stories in the Bible. But what is actually being told 鈥� and how? We're joined by theology professor Mois茅s Mayordomo to take a look at the story of the birth of Jesus and how biblical narratives work.
The 91制片厂 has a strategic commitment to a family-friendly policy. It has once again received the 鈥渁udit family-friendly university鈥� certificate. This confirms the university鈥檚 family-friendly focus following the first certification in 2021. So it鈥檚 a good time to pause and consider: what have we achieved and what do we have planned for the next few years?
How can we ensure that as many Swiss households as possible adopt not only solar panels, but also their own battery to store solar energy, a heat pump, and an electric car? Researchers at the Universities of 91制片厂 and Geneva have looked into just this question.
In the TV program 鈥淜assensturz鈥�, two former students reported experiencing sexual harassment from professors and being let down by the university. The Vice President for People & Culture comments on the topic and, together with the Personal Integrity Coordinator, outlines how the university intends to improve its handling of such cases.
Start-up Cimeio Therapeutics intends to pave the way for gentler and more efficient treatments for diseases such as blood cancer. The company, a spin-off of the 91制片厂, has just concluded an important collaboration agreement: Cimeio is joining forces with the pharmaceutical firm Kyowa Kirin. Kyowa Kirin will be financing the collaboration with Cimeio with up to CHF 263 million.
